I think you will be happy if data from 661 makes the stock pop 20 dollars, which hopefully it does in q1. That being said, do you know if there is a poison pill? As well, whats the best SVR24 data with the all oral GILD regimen. Being a physician, there is no way that the HepC market is really that big, maybe if ObamaCare comes to fruition in 2014 more indigent people can get covered for this expensive therapy. The value of VRTX is the CF platform, and trying to ride a diminishing wave of Incivek to fund the research to do so. VRTX won't be bought.
I'd like a 20 buck pop as long as the stock isn't at 10 when it happens. others on this board have said vrtx has a PP in place for a hostile takeover but I agree that nobody will buy them out now. They need a new drug on top of what they are doing now to even get a chance at someone looking at them. At 13-15B, not many can do this and won't right now. VRTX just has to discover stuff on their own and move fast before their income stream dies off.